Bicara Therapeutics (BCAX) Q2 2025 Earnings

13MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-1.6
-1.18
-0.75
-0.33

Details

Expected EPS
-0.415
Actual EPS
-0.68
Surprise EPS
-0.27
Surprise Percent
+63.86%

Description

Bicara Therapeutics (BCAX) has reported earnings of -0.68 per share for Q2 2025.

0 Comments

Share your thoughts